Command Palette

Search for a command to run...

ARTEMISMED

217.331.18 (0.55%)

Quarterly ResultsProfit & LossBalance SheetCash Flow

Key Insights

POSITIVE
  • Net sales increased to ₹239.9 crore, indicating strong demand in the latest quarter.
  • Operating profit margin improved to 6.8%, showing better cost management and efficiency.
  • Net profit rose to ₹22.92 crore, reflecting positive financial health and profitability growth.
NEGATIVE
  • Company experienced a cash flow shortfall with a 10% decrease this year [Dummy Data]
  • Company’s strategic partnerships have yet to generate expected growth. [Dummy Data]
  • Company’s EBITDA shrank at a CAGR of -8% over the past 3 years. [Dummy Data]
Quarterly Results Data
FieldTrendMar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25
Revenue
225.24223.20241.42232.39239.90254.96274.70272.35
Expenses
206.90205.97218.31214.38223.58232.10242.98246.97
Operating Profit
18.3417.2423.1118.0116.3222.8631.7225.38
Other Income
1.904.407.448.8012.356.937.657.46
Interest
8.578.137.9887.837.387.196.75
Depreciation
11.0410.8011.1711.4511.7411.1611.7112.44
Profit Before Tax
20.2421.6430.5526.8128.6629.7939.3829.76
Tax
5.935.128.426.215.748.599.377.53
Net Profit
14.3016.5222.1320.6022.9221.203022.23
EPS in Rs
1.041.141.421.321.471.351.901.41